Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with an additional office in Weston, Massachusetts.

Outperform Votes

Underperform Votes

Community Sentiment

Safeguard Scientifics has received 52.03% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Safeguard Scientifics and other stocks. Vote “Outperform” if you believe SFE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SFE will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.0 Company Ownership

In the past three months, Safeguard Scientifics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $470,221.00 in company stock and sold $0.00 in company stock.

Miscellaneous

Receive SFE News and Ratings via Email

Sign-up to receive the latest news and ratings for SFE and its competitors with MarketBeat's FREE daily newsletter.

Safeguard Scientifics (NYSE:SFE) Frequently Asked Questions

How has Safeguard Scientifics' stock been impacted by COVID-19 (Coronavirus)?

Safeguard Scientifics' stock was trading at $6.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SFE stock has increased by 6.0% and is now trading at $7.39. View which stocks have been most impacted by Coronavirus.

How often does Safeguard Scientifics pay dividends? What is the dividend yield for Safeguard Scientifics?

Safeguard Scientifics declared a dividend on Thursday, November 7th. Investors of record on Monday, December 23rd will be paid a dividend of $1.00 per share on Monday, December 30th. The ex-dividend date is Friday, December 20th. View Safeguard Scientifics' dividend history.

Has Safeguard Scientifics been receiving favorable news coverage?

News articles about SFE stock have been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Safeguard Scientifics earned a news impact score of -5.0 on InfoTrie's scale. They also gave news coverage about the asset manager a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutSafeguard Scientifics.

Are investors shorting Safeguard Scientifics?

Safeguard Scientifics saw a increase in short interest in May. As of May 15th, there was short interest totaling 405,400 shares, an increase of 10.9% from the April 30th total of 365,600 shares. Based on an average trading volume of 98,600 shares, the days-to-cover ratio is currently 4.1 days. Currently, 2.0% of the shares of the company are short sold. View Safeguard Scientifics' Current Options Chain.

Which major investors are selling Safeguard Scientifics stock?

SFE stock was sold by a variety of institutional investors in the last quarter, including Voss Capital LLC, Bank of New York Mellon Corp, Nuveen Asset Management LLC, Prescott Group Capital Management L.L.C., Morgan Stanley, First Manhattan Co., Squarepoint Ops LLC, and BlackRock Inc.. View insider buying and selling activity for Safeguard Scientifics.

How do I buy shares of Safeguard Scientifics?

Shares of SFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Safeguard Scientifics' stock price today?

One share of SFE stock can currently be purchased for approximately $7.39.

How big of a company is Safeguard Scientifics?

Safeguard Scientifics has a market capitalization of $152.75 million. The asset manager earns $54.56 million in net income (profit) each year or $2.64 on an earnings per share basis.